Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.796
+0.001 (0.16%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vor Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 55 | 153 | 437 | 433 | - | - | |
| Market Cap Growth | -66.56% | -65.05% | 0.75% | - | - | - | |
| Enterprise Value | 25 | 29 | 341 | 225 | - | - | |
| Last Close Price | 0.79 | 2.25 | 6.65 | 11.62 | - | - | |
| PB Ratio | 0.75 | 1.01 | 1.74 | 2.00 | - | - | |
| P/TBV Ratio | 0.66 | 1.01 | 1.74 | 2.00 | - | - | |
| Debt / Equity Ratio | 0.45 | 0.24 | 0.16 | 0.08 | 0.38 | - | |
| Quick Ratio | 4.38 | 8.81 | 17.55 | 20.43 | 4.76 | 2.96 | |
| Current Ratio | 4.69 | 9.04 | 18.06 | 21.12 | 4.81 | 3.45 | |
| Return on Equity (ROE) | -90.79% | -58.74% | -39.45% | -52.09% | -155.02% | -2483.16% | |
| Return on Assets (ROA) | -43.51% | -31.67% | -21.55% | -27.09% | -63.23% | -120.20% | |
| Return on Capital (ROIC) | -46.50% | -33.10% | -22.29% | -28.68% | -73.05% | -244.21% | |
| Earnings Yield | -212.65% | -77.26% | -21.09% | -15.90% | - | - | |
| FCF Yield | -188.88% | -66.44% | -21.44% | -16.86% | - | - | |
| Buyback Yield / Dilution | -10.66% | -69.89% | -18.30% | -15548.00% | -85.85% | -30.96% | |
| Total Shareholder Return | -10.66% | -69.89% | -18.30% | -15548.00% | -85.85% | -30.96% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.